A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma.

ABSTRACT:

SUBMITTER: Ramasamy K 

PROVIDER: S-EPMC8417099 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature